114 related articles for article (PubMed ID: 8350633)
1. Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meeting report and review.
Potter MN; Cross NC; van Dongen JJ; Saglio G; Oakhill A; Bartram CR; Goldman JM
Leukemia; 1993 Aug; 7(8):1302-14. PubMed ID: 8350633
[TBL] [Abstract][Full Text] [Related]
2. Minimal residual disease detection in human leukemias: biologic and clinical significance.
Saglio G
Acta Haematol Pol; 1995; 26(2 Suppl 1):19-24. PubMed ID: 7653231
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of PCR in diagnosis and follow-up of leukaemia and lymphoma: report of the third Workshop of the Molecular Biology/BMT study group.
Hughes TP; Ambrosetti A; Barbu V; Bartram C; Battista R; Biondi A; Chiamenti A; Cimino G; Ernst P; Frassoni F
Leukemia; 1991 Jun; 5(6):448-51. PubMed ID: 2056768
[TBL] [Abstract][Full Text] [Related]
4. [Molecular diagnosis of leukemia and lymphoma].
Miwa H; Kita K; Masuya M; Nishii K; Morita N; Shirakawa S
Rinsho Byori; 1991 Oct; 39(10):1072-8. PubMed ID: 1762182
[TBL] [Abstract][Full Text] [Related]
5. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
Chan DW; Liang R; Kwong YL; Chan V
Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
[TBL] [Abstract][Full Text] [Related]
6. tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease.
Breit TM; Beishuizen A; Ludwig WD; Mol EJ; Adriaansen HJ; van Wering ER; van Dongen JJ
Leukemia; 1993 Dec; 7(12):2004-11. PubMed ID: 8255100
[TBL] [Abstract][Full Text] [Related]
7. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.
Boeckx N; Willemse MJ; Szczepanski T; van der Velden VH; Langerak AW; Vandekerckhove P; van Dongen JJ
Leukemia; 2002 Mar; 16(3):368-75. PubMed ID: 11896540
[TBL] [Abstract][Full Text] [Related]
8. Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: a comparison between cytogenetic and polymerase chain reaction analyses.
Izraeli S; Janssen JW; Haas OA; Harbott J; Brok-Simoni F; Walther JU; Kovar H; Henn T; Ludwig WD; Reiter A
Leukemia; 1993 May; 7(5):671-8. PubMed ID: 8483319
[TBL] [Abstract][Full Text] [Related]
9. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.
van der Velden VH; Hochhaus A; Cazzaniga G; Szczepanski T; Gabert J; van Dongen JJ
Leukemia; 2003 Jun; 17(6):1013-34. PubMed ID: 12764363
[TBL] [Abstract][Full Text] [Related]
10. [Residual disease: the hematologist's point of view].
Quesnel B; Preudhomme C
Bull Cancer; 2001 Jun; 88(6):571-5. PubMed ID: 11459703
[TBL] [Abstract][Full Text] [Related]
11. [Molecular diagnosis of leukemia and lymphoma].
Iida S; Ueda R
Rinsho Byori; 1994 Apr; 42(4):364-71. PubMed ID: 8176845
[TBL] [Abstract][Full Text] [Related]
12. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction.
van Dongen JJ; Breit TM; Adriaansen HJ; Beishuizen A; Hooijkaas H
Leukemia; 1992; 6 Suppl 1():47-59. PubMed ID: 1548936
[TBL] [Abstract][Full Text] [Related]
13. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
Mackinnon S; Barnett L; Heller G
Bone Marrow Transplant; 1996 Apr; 17(4):643-7. PubMed ID: 8722369
[TBL] [Abstract][Full Text] [Related]
14. Detection and monitoring of minimal residual disease by quantitative real-time PCR.
Schüler F; Dölken G
Clin Chim Acta; 2006 Jan; 363(1-2):147-56. PubMed ID: 16154122
[TBL] [Abstract][Full Text] [Related]
15. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
[TBL] [Abstract][Full Text] [Related]
16. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of detection of monoclonality in remission marrow in acute lymphoblastic leukemia in childhood. Australian and New Zealand Children's Cancer Study Group.
Brisco MJ; Condon J; Hughes E; Neoh SH; Nicholson I; Sykes PJ; Tauro G; Ekert H; Waters K; Toogood I
Leukemia; 1993 Oct; 7(10):1514-20. PubMed ID: 8412313
[TBL] [Abstract][Full Text] [Related]
18. The polymerase chain reaction: a new tool for the detection of minimal residual disease in haematological malignancies.
Fey MF; Kulozik AE; Hansen-Hagge TE; Tobler A
Eur J Cancer; 1991; 27(1):89-94. PubMed ID: 1826449
[TBL] [Abstract][Full Text] [Related]
19. [Detection of minimal residual leukemia using polymerase chain reaction method].
Naoe T
Rinsho Byori; 1996 Jun; 44(6):535-40. PubMed ID: 8752731
[TBL] [Abstract][Full Text] [Related]
20. Molecular detection and characterization of clonal cell populations in acute lymphocytic leukemia by analysis of conformational polymorphisms of cRNA molecules of rearranged T-cell-receptor-gamma and immunoglobulin heavy-chain genes.
Koch OM; Volkenandt M; Göker E; Buer J; Probst M; Banerjee D; Danenberg PV; Bertino JR
Leukemia; 1994 Jun; 8(6):946-52. PubMed ID: 8207989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]